Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |